Double Medical Technology Inc (002901) - Total Assets
Based on the latest financial reports, Double Medical Technology Inc (002901) holds total assets worth CN¥5.03 Billion CNY (≈ $735.99 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 002901 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Double Medical Technology Inc - Total Assets Trend (2013–2025)
This chart illustrates how Double Medical Technology Inc's total assets have evolved over time, based on quarterly financial data. See Double Medical Technology Inc (002901) shareholders funds for net asset value and shareholders' equity analysis.
Double Medical Technology Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Double Medical Technology Inc's total assets of CN¥5.03 Billion consist of 67.8% current assets and 32.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 24.8% |
| Accounts Receivable | CN¥302.87 Million | 6.2% |
| Inventory | CN¥1.23 Billion | 25.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥116.93 Million | 2.4% |
| Goodwill | CN¥61.86 Million | 1.3% |
Asset Composition Trend (2013–2025)
This chart illustrates how Double Medical Technology Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Double Medical Technology Inc market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Double Medical Technology Inc's current assets represent 67.8% of total assets in 2025, an increase from 63.0% in 2013.
- Cash Position: Cash and equivalents constituted 24.8% of total assets in 2025, up from 12.5% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 10.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 25.1% of total assets.
Double Medical Technology Inc Competitors by Total Assets
Key competitors of Double Medical Technology Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
Double Medical Technology Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.23 | 3.21 | 3.13 |
| Quick Ratio | 2.71 | 1.78 | 2.26 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.64 Billion | CN¥1.98 Billion | CN¥1.43 Billion |
Double Medical Technology Inc - Advanced Valuation Insights
This section examines the relationship between Double Medical Technology Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.66 |
| Latest Market Cap to Assets Ratio | 0.53 |
| Asset Growth Rate (YoY) | 11.4% |
| Total Assets | CN¥4.92 Billion |
| Market Capitalization | $2.62 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Double Medical Technology Inc's assets below their book value (0.53x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Double Medical Technology Inc's assets grew by 11.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Double Medical Technology Inc (2013–2025)
The table below shows the annual total assets of Double Medical Technology Inc from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.92 Billion ≈ $720.57 Million |
+11.43% |
| 2024-12-31 | CN¥4.42 Billion ≈ $646.63 Million |
-4.76% |
| 2023-12-31 | CN¥4.64 Billion ≈ $678.94 Million |
+17.83% |
| 2022-12-31 | CN¥3.94 Billion ≈ $576.18 Million |
+16.50% |
| 2021-12-31 | CN¥3.38 Billion ≈ $494.58 Million |
+27.75% |
| 2020-12-31 | CN¥2.65 Billion ≈ $387.14 Million |
+18.17% |
| 2019-12-31 | CN¥2.24 Billion ≈ $327.60 Million |
+34.46% |
| 2018-12-31 | CN¥1.67 Billion ≈ $243.65 Million |
+19.93% |
| 2017-12-31 | CN¥1.39 Billion ≈ $203.16 Million |
+93.08% |
| 2016-12-31 | CN¥719.06 Million ≈ $105.22 Million |
+28.10% |
| 2015-12-31 | CN¥561.32 Million ≈ $82.14 Million |
+2.94% |
| 2014-12-31 | CN¥545.28 Million ≈ $79.79 Million |
+84.10% |
| 2013-12-31 | CN¥296.19 Million ≈ $43.34 Million |
-- |
About Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products. The company was formerly known as Xiamen Da Bo Ying J… Read more